NCT00152204View on ClinicalTrials.gov

The Community Effectiveness of IPTi in Southern Tanzania

PHASE3UnknownINTERVENTIONAL
Enrollment

13,000

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2008

Conditions
Malaria, FalciparumAnemia
Interventions
DRUG

Sulfadoxine-pyrimethamine used for IPTi

Doses of IPTi with SP delivered alongside doses 2 \& 3 of DTP/HB vaccination and alongside measles vaccination

DRUG

IPTi

Doses of IPTi with SP delivered alongside doses 2 \& 3 of DTP/HB vaccination and alongside measles vaccination

Trial Locations (1)

SLP 78373

Ifakara Health Research & Development Centre, Dar es Salaam

Sponsors
All Listed Sponsors
collaborator

Ifakara Health Research and Development Centre

OTHER

collaborator

Ministry of Health, Tanzania

OTHER_GOV

collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

London School of Hygiene and Tropical Medicine

OTHER

lead

Swiss Tropical & Public Health Institute

OTHER